Skip to main content
TipRanks
Go Ultimate75% OFF

Xeris Pharmaceuticals (2B30) Balance Sheet

0 Followers

Xeris Pharmaceuticals Balance Sheet

Xeris Pharmaceuticals's total assets for Q3 2026 were $423.22M, an increase of 2.75% from the previous quarter. DE:2B30 total liabilities were $374.44M for the fiscal quarter, a 11.20% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.

Balance Sheet
Balance SheetDec 25Dec 24Dec 23Dec 22Dec 21
$ 383.53M$ 323.06M$ 322.60M$ 344.52M$ 304.36M
$ 369.84M$ 352.68M$ 329.38M$ 299.33M$ 209.13M
$ 13.69M$ -29.61M$ -6.78M$ 45.19M$ 95.23M

Currency in USD

Xeris Pharmaceuticals Liabilities to Assets

0150M300M450M0 %80 %160 %240 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets